An Outlook on 2026 AI IPOs
A Historic Reopening of the IPO Window After a long period of subpar issuance, the U.S. IPO market is staging a strong comeback in 2026,…
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
Retail Rush at the Top? What the ASX’s Hot-Stock Frenzy Means
Retail participation on the ASX jumped through the September quarter as the index broke above 9000, with online retail investors…
Rare Earths Just Got a Policy Premium – But Not Where You Think
Australia rare earths strategy in focus, the sharp rally in Australian Strategic Materials (ASX: ASM) this week highlights how sensitive…
Cynata Therapeutics (ASX: CYP): Speculative Investment Analysis
Business Overview Cynata Therapeutics is a clinical-stage biotechnology company developing cell therapies based on Cymerus, its induced pluripotent stem cell…
Gold & Silver Surge Playbook: Who Wins and What to Watch
Gold's explosive rally past US$4,150 an ounce and silver's surge beyond US$52.50 an ounce have transformed global sentiment toward precious…
Socials
Monthly Investor Memo
Delivered Monthly - 2026